1Magister of Pharmacy, Faculty of Pharmacy, Universitas Muslim Indonesia, Makassar, Indonesia
2Departement Medicinal Chemistry, Faculty of Pharmacy, Universitas Taddulako, Palu, Indonesia
3Magister of Pharmacy, Faculty of Pharmacy, Universitas Halu Oleo, Kendari, Indonesia
4Magister of Pharmacy, Faculty of Pharmacy, Universitas Hasanuddin, Makassar, Indonesia
5Departement of Pharmacognosy-Phytochemistry, Faculty of Pharmacy, Universitas Muslim Indonesia, Makassar, Indonesia
*Corresponding Author E-mail: ahmad.najib@umi.ac.id
Online Published on 29 May, 2026.
The research involved the extraction and in vitro screening of bioactive compounds from several plant samples. The extraction process yielded the following extract percentages: Antidesma bunius (2.28%), Cordia myxa (1.93%), Syzygium cumini (1.87%), and Syzygium malacense (2.97%). Subsequently, each sample was fractionated using n-hexane, ethyl acetate, and methanol. The extracts and fractions were then tested in vitro for their inhibitory activity against α-glucosidase enzyme using a microplate reader. The findings revealed that all extracts demonstrated notable inhibitory activity, with IC50 values of 5.66 ppm, 6.03 ppm, 6.17 ppm, and 6.13 ppm respectively. Importantly, these values are lower than the IC50 of the standard drug, Acarbose (6.85 ppm), highlighting the superior α-glucosidase inhibitory potential of the plant extracts. This indicates their promise as natural antidiabetic agents.
Antidesma bunius, Antidiabetic, Cordia myxa, Ethnopharmacological, Syzygium cumini, Syzygium malacense